Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population

European Heart Journal

Volumn 20, Issue 23, 1999, Pages 1736-1744

  Talwar, S ^a   Squire, I B ^a   Davies, J E ^a   Barnett, D B ^a   Ng, L L ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Brain natriuretic peptide; Chemiluminescence; Heart failure; Plasma; Wall motion index

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGE; AGED; AMINO TERMINAL SEQUENCE; ANAMNESIS; ARTICLE; BLOOD LEVEL; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; ELECTROCARDIOGRAPHY; FEMALE; GENDER; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE WALL MOTION; HIGH RISK POPULATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRECURSOR; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEX DIFFERENCE; SYSTOLE; VALVULAR HEART DISEASE;

EID: 0032752946     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1999.1694     Document Type: Article

References (29)

1. McDonagh TA, Robb SD, Murdoch DR. Biochemical detection of left-ventricular systolic dysfunction. Lancet. 351:1998;9-13.
2. Cowie MR, Struthers AD, Wood DA. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet. 350:1997;1349-1353.
3. Richards MA, Nicholls MG, Yandle TG. Plasma Nterminal pro-brain natriuretic peptide and adrenomedullin - New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation. 97:1998;1921-1929.
4. Davidson NC, Nass AA, Hanson JK, Kennedy NSJ, Coutie WJ, Struthers AD. Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-Terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. Am J Cardiol. 77:1996;828-831.
5. Choy AMJ, Darbar D, Lang CC. Detection of left ventricular dysfunction after acute myocardial infarction; comparison of clinical, echocardiographic, and neurohormonal methods. Br Heart J. 72:1994;16-22.
6. Hunt PJ, Yandle TG, Nicholls MG, Richards AM, Espiner EA. The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma. Biochem Biophys Res Commun. 214:1995;1175-1183.
7. Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-proBNP): a new marker of cardiac impairment. Clin Endocrinol. 47:1997;287-296.
8. Muders F, Kromer EP, Griese DP. Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction. Am Heart J. 134:1997;442-449.
9. McClure SJ, Caruana L, Davie AP, Goldthorp S, McMurray JJV. Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care. Br Med J. 317:1998;516-519.
10. Davie AP, Francis CM, Love MP. Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction. Br Med J. 312:1996;222.
11. Rihal CS, Davis KB, Kennedy JW, Gersch BJ. The utility of clinical, electrocardiographic and roentgenographic variables in prediction of left ventricular function. Am J Cardiol. 75:1995;220-223.
12. Houghton AR, Sparrow NJ, Toms E, Cowley AJ. Should general practitioners use the electrocardiogram to select patients with suspected heart failure for echocardiography? Int J Cardiol. 62:1997;31-36.
13. Hughes, D, Talwar, S, Squire, IB, Davies, JE, Ng, LL, An Immunoluminometric assay (ILMA) for N-terminal proBNP: development of a test for left ventricular dysfunction, Clin Sci.
14. Berning J, Rokkedal Neilsen J, Launbjerg J, Fogh J, Mickley H, Andersen PE. Rapid estimation of left ventricular ejection fraction in acute myocardial infarction by echocardiographic wall motion analysis. Cardiology. 80:1992;257-266.
15. Rifkin RD, Koito H. Comparison with radionuclide angiography of two new geometric and four non-geometric models for echocardiographic estimation of left ventricular ejection fraction using segmental wall motion scoring. Am J Cardiol. 65:1990;1485-1490.
16. Heger JJ, Weyman AE, Wann LS, Rogers EW, Dillon JC, Feigenbaum H. Cross-sectional echocardiographic analysis of the extent of left ventricular asynergy in acute myocardial infarction. Circulation. 61:1980;113-118.
17. Berning J, Steensgaard-Hansen F. Early estimation of risk by echocardiographic determination of wall motion index in an unselected population with acute myocardial infarction. Am J Cardiol. 65:1990;567-576.
18. Kober L, Torp-Pederson C, Carlsen J, Videbaek R, Egeblad H. An echocardiographic method for selecting high risk patients shortly after acute myocardial infarction, for inclusion in multicentre studies. Eur Heart J. 15:1994;1616-1620.
19. Kober L, Torp-Pedersen C, Carlsen JE. A clinical trial of the angiotensin converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 333:1995;1670-1676.
20. Miyatake K, Izumi S, Okamoto M. Semiquantitative grading of severity of mitral regurgitation by real-time two-dimensional doppler flow imaging technique. J Am Coll Cardiol. 7:1986;82-88.
21. Hanley JA, McNeill BJ. The meaning and use of the area under a receiver operator characteristic (ROC) curve. Radiology. 143:1982;29-36.
22. Omland T, Aakvaag A, Vik-Mo H. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment. Heart. 76:1996;232-237.
23. Cowburn PJ, Cleland JGF, Coats AJS, Komajda M. Risk stratification in Chronic Heart Failure. Eur Heart J. 19:1998;696-710.
24. Madsen BK, Videbaek R, Stokholm H, Mortensen LS, Hansen JF. Prognostic value of echocardiography in 190 patients with chronic congestive heart failure. Cardiology. 87:1996;250-256.
25. Mizuno Y, Yasue H, Oshima S. Effects of angiotensin-converting enzyme inhibitor on plasma B-type natriuretic peptide levels in patients with acute myocardial infarction. J Card Fail. 3:1997;287-293.
26. Sanderson JE, Chan WWM, Hung YT. Effect of low-dose beta-blockers on atrial and ventricular (b-type) natriuretic factor in heart failure - a double blind, randomised comparison of metoprolol and a third generation vasodilating beta-blocker. Br Heart J. 74:1995;502-507.
27. Tsutamoto T, Wada A, Maeda K. Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure. Am Heart J. 134:1997;910-916.
28. Jensen KT, Carstens J, Ivarsen P, Pederson EB. A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases. Scan J Clin Lab Invest. 57:1997;529-540.
29. Christian TF, Miller TD, Chareonthaitawee P, Hodge DO, O'Connor MK, Gibbons RJ. Prevalence of normal resting left ventricular function with normal resting electrocardiograms. Am J Cardiol. 1996:1996;1295-1298.